Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
ACQUIRED COMPANY
 
My Lists

Advanced Stent Technologies  Acquired by Boston Scientific (2004)

6900 Koll Center Drive #415
Pleasanton, CA 94566
USA
(925)-931-9990
Website Company Summary Management Team
Board

Outside board: (May no longer be on the board) Jerry Caulder (Advanced Stent Technologies Chairman);  Charles J. Davidson (Northwestern University);  John G. McCutcheon (Emphasys Medical CEO) Doug Hickey (Emerson Electric General Counsel)
Company

Business description: Advanced Stent Technologies, Inc. (AST) designs, develops and manufactures stents and stent delivery systems for the treatment of atherosclerosis at bifurcations in the coronary vasculature. Our premier product – the SLK-View™ Stent and Delivery System – treats diseased bifurcations by providing stability to the main artery while maintaining access to the side branch vessel. AST has obtained a CE Mark for the SLK-View™ Stent and Delivery System. It is now commercially available outside of the United States. In the United States, we recently began our 30-human feasibility study for the FDA under an Investigational Device Exemption (IDE). AST recently completed an Outside of the United States (OUS) 80 patient study. AST continues to pioneer the research and development of innovative devices for the treatment of complicated lesions. We are currently developing the SLK-View™ DSX™ Stent and Delivery System, a dual exchange device for the treatment of lesions at bifurcations. AST believes that we are the market leader in solutions for complicated lesions.
Capital

Ownership: Acquired by Boston Scientific (2004)

Last Tweets


 

Last Mentions


Overview
Record updated: Oct 2004
Sector: Medical
Year Founded: 1999
Ownership: Acquired by Boston Scientific (2004)